The Scientist

» cancer and disease/medicine

Most Recent

image: British Health Open for Research

British Health Open for Research

By | September 12, 2012

Giving researchers access to the health records of 52 million people in England could prove invaluable to biomedical scientists.

1 Comment

image: Double-Edged TB Drug

Double-Edged TB Drug

By | September 12, 2012

A cheap pain reliever that can kill drug-resistant, tuberculosis-causing bacteria may never be tested.

2 Comments

image: Lasker Winners Announced

Lasker Winners Announced

By | September 10, 2012

This year’s prizes are awarded for advances in liver transplantation, cell biology, and leadership in biomedical science.

0 Comments

image: Fears over Fast-Tracking Drugs

Fears over Fast-Tracking Drugs

By | September 10, 2012

Doctors question whether a government initiative to speed approval for promising new drugs is ensuring safety.

0 Comments

image: Robot Legs Obey Brain

Robot Legs Obey Brain

By | September 7, 2012

A pair of mechanical leg braces that are controlled by their wearer’s brain signals could help paralyzed patients walk again.

1 Comment

image: Get a Whiff of This

Get a Whiff of This

By | September 1, 2012

Can electronic noses come close to the real thing?

5 Comments

image: Pleasant to the Touch

Pleasant to the Touch

By | September 1, 2012

Scientists hope an understanding of nerve fibers responsive only to gentle touch will give insight into the role the sense plays in social bonding.

0 Comments

image: Opinion: Younger Is Better

Opinion: Younger Is Better

By | August 31, 2012

Stem cells collected from younger donors are more effective for transplantation and regenerative medicine than those from older individuals.

9 Comments

image: Dieting Monkeys Don't Live Longer

Dieting Monkeys Don't Live Longer

By | August 29, 2012

The latest news from a long-term study of calorie restriction in rhesus macaques shows better health, but no boost in lifespan, in monkeys who eat less.

11 Comments

image: Epigenetic Drug Improves Cholesterol Levels

Epigenetic Drug Improves Cholesterol Levels

By | August 28, 2012

Results from a Phase II trial for cardiovascular disease with an epigenetic target therapy show promise.

1 Comment

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech